PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: In Press PR Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BBI Solutions Launch of Cutting Edge, Sensitivity Enhancing Technologies At Medica 2013 - New and unique sensitivity enhancing technology for assay development will be launched by BBI Solutions at Medica 2013, alongside detailed information on its portfolio of critical reagents and contract manufacturing services - BBISolutions.com
BBI Solutions Launch of Cutting Edge, Sensitivity Enhancing Technologies At Medica 2013

 

NewswireToday - /newswire/ - Cardiff, Wales, United Kingdom, 2013/10/28 - New and unique sensitivity enhancing technology for assay development will be launched by BBI Solutions at Medica 2013, alongside detailed information on its portfolio of critical reagents and contract manufacturing services - BBISolutions.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

BBI Solutions will be launching new and unique sensitivity enhancing technology in Hall 1, Booth F24 at Medica 2013, alongside detailed information on its portfolio of critical reagents and contract manufacturing services. Specialists from BBI Solutions, formed by the merger of four of its well-known and established core business entities BBInternational, BBI Enzymes, Scipac and Vision Biotech, will also be engaging with customers and giving new, live on-booth presentations throughout the show.

Once again leading the way in assay development, BBI Solutions (bbisolutions.com) has arranged a series of technical presentations and demonstrations that will highlight how its innovative technology can enable manufacturers to produce more accurate and reliable clinical assays. On each day, information will be presented on the Novarum mobile technology and how it can revolutionize Lateral Flow assays, particularly their use as part of a drive towards ‘connected healthcare’. Day Two sees the launch of the new enhanced sensitivity technology that includes signal enhancement. A presentation will be given on BBI Solutions’ Booth F1 at 11.30am and full details will be revealed. On Day 3, BBI Solutions will show how its new latest generation of recombinant Fab monoclonal antibodies can enhance assay performance. Attendees are able to guarantee their places for all these presentations by registering their interest at BBI Solutions' website.

Visitors to the show will also have the opportunity to discover all that BBI Solutions has to offer the global diagnostic and healthcare markets. The product range includes a comprehensive range of antibodies, proteins, disease state plasma, enzymes and nanoparticles, while experts will be on hand to discuss BBI Solutions’ expertise in contract manufacturing of assays and raw materials along with assay development services.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: In Press PR Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BBI Solutions Launch of Cutting Edge, Sensitivity Enhancing Technologies At Medica 2013

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Carly Unsworth - BBISolutions.com 
+44(0)14 8867 4200 info[.]bbisolutions.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any In Press PR Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From In Press PR Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)